PhD or Honours

Heart transplantation is currently the only viable option for patients with advanced heart failure. An exciting possible new therapy is to use stem cells or their derivatives to replace damaged heart tissue. We have established feasibility of pluripotent stem cell derived cardiomyocyte transplantation in pre-clinical models and are working to optimize the efficacy and safety of this novel therapy.

Supervsior: Associate Professor James Chong -